Neoadjuvant endocrine therapy for estrogen receptor-positive primary breast cancer.

Yamamoto, Yutaka; Goto-Yamaguchi, Lisa; Takeno, Masako; Yamamoto-Ibusuki, Mutsuko

Yamamoto, Yutaka; Goto-Yamaguchi, Lisa; Takeno, Masako; Yamamoto-Ibusuki, Mutsuko.

Afiliação

Yamamoto Y; Department of Breast and Endocrine Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan. yyamamoto@kumamoto-u.ac.jp.
Goto-Yamaguchi L; Department of Breast and Endocrine Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Takeno M; Department of Breast and Endocrine Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Yamamoto-Ibusuki M; Department of Breast and Endocrine Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.

Chin Clin Oncol ; 9(3): 30, 2020 06.

Article em En | MEDLINE | ID: mdl-32279525

Assuntos

Antineoplásicos Hormonais/uso terapêutico; Neoplasias da Mama/tratamento farmacológico; Terapia Neoadjuvante/métodos; Antineoplásicos Hormonais/farmacologia; Neoplasias da Mama/patologia; Feminino; Humanos

Palavras-chave

Neoadjuvant endocrine treatment (NAE); breast cancer; estrogen receptor-positive (ER-positive)

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Antineoplásicos Hormonais / Terapia Neoadjuvante Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google